Results 271 to 280 of about 16,072,038 (292)

Alterations of triglyceride, HDL-C and non-HDL-C levels in patients with acute coronary syndrome

Atherosclerosis, 2015
P. Koncsos, P. Fülöp, I. Juhász, K. Bíró, L. Márk, G. Simonyi, G.Y. Paragh   +6 more
openaire   +1 more source

HDL Cholesterol and Protective Factors in Atherosclerosis

Circulation, 2004
Gerd Assmann
exaly  

HDL-targeted therapies: progress, failures and future

Nature Reviews Drug Discovery, 2014
Bronwyn A Kingwell, Norman E Miller, Kingwell Bronwyn A   +2 more
exaly  

PARADOXICAL FALLS IN HDL-C WITH FENOFIBRATE

Atherosclerosis Supplements, 2008
G. Magee, P. Sharpe
openaire   +1 more source

Endothelial and Antithrombotic Actions of HDL

Circulation Research, 2006
Chieko Mineo, Hiroshi Deguchi, John H Griffin   +2 more
exaly  

Bad HDL-C Responders to Statins.

2006
Lowering high levels of low-density lipoprotein cholesterol (LDL-C) is the primary aim in the prevention of cardiac events. However, low levels of high-density lipoprotein cholesterol (HDL-C) are also associated with an increased risk of ischemic heart disease. Lipid-lowering drugs are known to decrease LDL-C and to increase HDL-C slightly.
openaire   +1 more source

HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export

Circulation Research, 2015
Liming Hou, Wilfried Le Goff, John R Burnett   +2 more
exaly  

Unraveling the complexities of the HDL lipidome

Journal of Lipid Research, 2013
Marie Lhommé
exaly  

Reply: HDL-C and Mortality.

Journal of the American College of Cardiology, 2019
Dennis T, Ko, Jack V, Tu
openaire   +1 more source

Is raising HDL a futile strategy for atheroprotection?

Nature Reviews Drug Discovery, 2008
Robert A Hegele, Hegele Robert A
exaly